Breaking News in Primary Sclerosing Cholangitis: Bridging Gaps in Care

Nov 07 2026
Convention Center: Four Seasons Ballroom 1
12:30 PM - 2:00 PM
CE Credits CE Credits

Description

 Primary sclerosing cholangitis (PSC) is a rare, progressive chronic liver disease, often associated with inflammatory bowel disease, that can lead to severe liver damage, cirrhosis, and liver failure if left untreated. This engaging, newsroom-style live symposium will feature expert faculty who will discuss the latest clinical evidence and best practices for diagnosing and managing PSC and its related complications. This dynamic event will feature a professional host, a patient testimonial, and plenty of time to interact with and ask questions of the faculty, who are leaders in the field. Attendees will come away with an in-depth understanding of PSC diagnosis and management, including the latest information on emerging therapies in clinical trials. So, join us for Breaking News in PSC and learn from the best!

Objectives

  • Increased knowledge regarding the burden and consequences of untreated/undertreated PSC.
  • Increased knowledge regarding clinical data on emerging PSC therapies.
  • Greater competence related to implementing guideline-based diagnostic and surveillance tests into clinical practice for patients with suspected or confirmed PSC.
  • Greater confidence in their ability to design PSC treatment strategies that incorporate shared decision-making with patients.